![](Portal%20Page%20Template_files/dot_clear.gif) |
Division of Accounting
The Division of Accounting
is responsible for the analysis, reconciliation and
preparation of financial statements generated from
the internal FDA accounting system and presented in
statements that conform to Government-wide standards. The
FDA Division of Accounting has the overall responsibility
for the administration, functional leadership and technical
direction of an accounting system subject to managing
FDA's multi-million dollar budget, including oversight
of 26 District Offices nationwide.
The FDA accounting
system is one of five recognized General Ledger/Financial
Management systems in the Department of Health and
Human Services. FDA is considered Agency Level
and reports directly to OMB, Treasury and DHHS. All
reports are subject to review and audit by GAO and
the Inspector General.
The Division of Accounting
is composed of two branches, the CFO Liaison Branch
and the Accounting Services Branch.
The Chief Financial
Officers (CFO) Liaison Branch is responsible for the
FDA's annual financial statement audit and produces
FDA's Chief Financial Officer's Annual Report. Created
in FY 2000, this branch deals with the ever increasing
demands of the annual audit.
The Accounting Services
Branch is comprised of the following:
- Accounting
Reports and Analysis Section
- Property Team
- Special Services Team (Applications, Obligations,
IPAC, Support)
|
![](https://webarchive.library.unt.edu/eot2008/20090512091924im_/http://www.fda.gov/oc/oms/ofm/graphics/dot_clear.gif) |
![](Portal%20Page%20Template_files/dot_clear.gif) |
Financial
Enterprise Solutions
|
|
![](Portal%20Page%20Template_files/dot_clear.gif) |
![](C:/Local Web Folders/OFM Internet/Templates/Buying Medicines and Medical Products Online_files/dot_clear(1).gif) |